Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $1.5 million.

  • Macrogenics' Other Non Operating Income fell 2785.65% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 3682.18%. This contributed to the annual value of $9.4 million for FY2024, which is 273.59% down from last year.
  • Latest data reveals that Macrogenics reported Other Non Operating Income of $1.5 million as of Q3 2025, which was down 2785.65% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Other Non Operating Income ranged from a high of $3.3 million in Q4 2023 and a low of $21000.0 during Q1 2021
  • For the 5-year period, Macrogenics' Other Non Operating Income averaged around $1.4 million, with its median value being $1.4 million (2025).
  • As far as peak fluctuations go, Macrogenics' Other Non Operating Income plummeted by 9708.74% in 2021, and later skyrocketed by 205211.27% in 2023.
  • Over the past 5 years, Macrogenics' Other Non Operating Income (Quarter) stood at $214000.0 in 2021, then soared by 282.71% to $819000.0 in 2022, then surged by 300.73% to $3.3 million in 2023, then tumbled by 36.44% to $2.1 million in 2024, then dropped by 26.75% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.4 million for Q2 2025, and $1.7 million during Q1 2025.